These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23319086)

  • 61. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.
    Carrat F; Fontaine H; Dorival C; Simony M; Diallo A; Hezode C; De Ledinghen V; Larrey D; Haour G; Bronowicki JP; Zoulim F; Asselah T; Marcellin P; Thabut D; Leroy V; Tran A; Habersetzer F; Samuel D; Guyader D; Chazouilleres O; Mathurin P; Metivier S; Alric L; Riachi G; Gournay J; Abergel A; Cales P; Ganne N; Loustaud-Ratti V; D'Alteroche L; Causse X; Geist C; Minello A; Rosa I; Gelu-Simeon M; Portal I; Raffi F; Bourliere M; Pol S;
    Lancet; 2019 Apr; 393(10179):1453-1464. PubMed ID: 30765123
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Direct-acting antiviral therapy of chronic hepatitis C improves liver fibrosis, assessed by histological examination and laboratory markers.
    Cheng CH; Chu CY; Chen HL; Lin IT; Wu CH; Lee YK; Hu PJ; Bair MJ
    J Formos Med Assoc; 2021 May; 120(5):1259-1268. PubMed ID: 33339709
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Noninvasive diagnosis of hepatic fibrosis in chronic hepatitis C.
    Stauber RE; Lackner C
    World J Gastroenterol; 2007 Aug; 13(32):4287-94. PubMed ID: 17708599
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Role of assessing liver fibrosis in management of chronic hepatitis C virus infection.
    Carmona I; Cordero P; Ampuero J; Rojas A; Romero-Gómez M
    Clin Microbiol Infect; 2016 Oct; 22(10):839-845. PubMed ID: 27677698
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C.
    Poynard T; Moussalli J; Munteanu M; Thabut D; Lebray P; Rudler M; Ngo Y; Thibault V; Mkada H; Charlotte F; Bismut FI; Deckmyn O; Benhamou Y; Valantin MA; Ratziu V; Katlama C;
    J Hepatol; 2013 Oct; 59(4):675-83. PubMed ID: 23712051
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents.
    Hsu WF; Lai HC; Su WP; Lin CH; Chuang PH; Chen SH; Chen HY; Wang HW; Huang GT; Peng CY
    BMC Gastroenterol; 2019 Apr; 19(1):63. PubMed ID: 31029101
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Improved fibrosis staging by elastometry and blood test in chronic hepatitis C.
    Calès P; Boursier J; Ducancelle A; Oberti F; Hubert I; Hunault G; de Lédinghen V; Zarski JP; Salmon D; Lunel F;
    Liver Int; 2014 Jul; 34(6):907-17. PubMed ID: 24102852
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Measurement of liver elasticity with acoustic radiation force impulse (ARFI) technology: an alternative noninvasive method for staging liver fibrosis in viral hepatitis.
    Goertz RS; Zopf Y; Jugl V; Heide R; Janson C; Strobel D; Bernatik T; Haendl T
    Ultraschall Med; 2010 Apr; 31(2):151-5. PubMed ID: 20306380
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison of transient elastography, serum markers and clinical signs for the diagnosis of compensated cirrhosis.
    Malik R; Lai M; Sadiq A; Farnan R; Mehta S; Nasser I; Challies T; Schuppan D; Afdhal N
    J Gastroenterol Hepatol; 2010 Sep; 25(9):1562-8. PubMed ID: 20796156
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Serum cystatin C: a non-invasive marker of liver fibrosis or of current liver fibrogenesis in chronic hepatitis C? .
    Ladero JM; Cárdenas MC; Ortega L; González-Pino A; Cuenca F; Morales C; Lee-Brunner A
    Ann Hepatol; 2012; 11(5):648-51. PubMed ID: 22947524
    [TBL] [Abstract][Full Text] [Related]  

  • 71. FibroScan, APRI, FIB4, and GUCI: Role in prediction of fibrosis and response to therapy in Egyptian patients with HCV infection.
    Yosry A; Fouad R; Alem SA; Elsharkawy A; El-Sayed M; Asem N; Hassan E; Ismail A; Esmat G
    Arab J Gastroenterol; 2016 Jun; 17(2):78-83. PubMed ID: 27353055
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Usefulness of noninvasive transient elastography for assessment of liver fibrosis stage in chronic hepatitis C.
    Takeda T; Yasuda T; Nakayama Y; Nakaya M; Kimura M; Yamashita M; Sawada A; Abo K; Takeda S; Sakaguchi H; Shiomi S; Asai H; Seki S
    World J Gastroenterol; 2006 Dec; 12(48):7768-73. PubMed ID: 17203518
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Watchful waiting with periodic liver biopsy versus immediate empirical therapy for histologically mild chronic hepatitis C. A cost-effectiveness analysis.
    Wong JB; Koff RS
    Ann Intern Med; 2000 Nov; 133(9):665-75. PubMed ID: 11074899
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis.
    Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D; Fard MK; Agcheli K
    J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Non-invasive assessment of liver fibrosis: time to move from cross-sectional studies to longitudinal ones.
    Kim SU; Han KH; Ahn SH
    J Gastroenterol Hepatol; 2010 Sep; 25(9):1472-3. PubMed ID: 20796140
    [No Abstract]   [Full Text] [Related]  

  • 76. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.
    Castera L; Friedrich-Rust M; Loomba R
    Gastroenterology; 2019 Apr; 156(5):1264-1281.e4. PubMed ID: 30660725
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C.
    Stasi C; Arena U; Zignego AL; Corti G; Monti M; Triboli E; Pellegrini E; Renzo S; Leoncini L; Marra F; Laffi G; Milani S; Pinzani M
    Dig Liver Dis; 2013 Oct; 45(10):840-3. PubMed ID: 23660078
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Noninvasive tools to assess hepatic fibrosis: ready for prime time?
    Schmeltzer PA; Talwalkar JA
    Gastroenterol Clin North Am; 2011 Sep; 40(3):507-21. PubMed ID: 21893271
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Noninvasive Assessment of Liver Fibrosis in Patients with Chronic Hepatitis B or C by Contrast-Enhanced Magnetic Resonance Imaging.
    Hako R; Kristian P; Jarčuška P; Haková I; Hockicková I; Schréter I; Janičko M
    Can J Gastroenterol Hepatol; 2019; 2019():3024630. PubMed ID: 31058108
    [No Abstract]   [Full Text] [Related]  

  • 80. Course of liver fibrosis in HIV-hepatitis C virus-coinfected patients depending on the response to hepatitis C therapy.
    Cartón JA; Collazos J; de la Fuente B; Asensi V
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):215-22. PubMed ID: 22734850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.